bioAffinity Technologies (BIAF) Competitors $0.50 0.00 (-0.24%) Closing price 04:00 PM EasternExtended Trading$0.50 +0.01 (+1.04%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BIAF vs. MOBQ, KPLT, ISDR, VIVK, WKEY, BGSF, GLE, XBP, PMEC, and SJShould you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include Mobiquity Technologies (MOBQ), Katapult (KPLT), Issuer Direct (ISDR), Vivakor (VIVK), WISeKey International (WKEY), BGSF (BGSF), Global Engine Group (GLE), XBP Europe (XBP), Primech (PMEC), and Scienjoy (SJ). These companies are all part of the "business services" industry. bioAffinity Technologies vs. Mobiquity Technologies Katapult Issuer Direct Vivakor WISeKey International BGSF Global Engine Group XBP Europe Primech Scienjoy bioAffinity Technologies (NASDAQ:BIAF) and Mobiquity Technologies (NASDAQ:MOBQ) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, community ranking, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations. Which has stronger valuation & earnings, BIAF or MOBQ? Mobiquity Technologies has lower revenue, but higher earnings than bioAffinity Technologies. Mobiquity Technologies is trading at a lower price-to-earnings ratio than bioAffinity Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiobioAffinity Technologies$9.36M0.97-$7.94M-$0.77-0.65Mobiquity Technologies$1.24M27.68-$6.53M-$0.95-1.81 Do insiders and institutionals hold more shares of BIAF or MOBQ? 1.6% of bioAffinity Technologies shares are owned by institutional investors. Comparatively, 14.2% of Mobiquity Technologies shares are owned by institutional investors. 35.1% of bioAffinity Technologies shares are owned by company insiders. Comparatively, 24.5% of Mobiquity Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer BIAF or MOBQ? bioAffinity Technologies currently has a consensus price target of $6.00, suggesting a potential upside of 1,102.89%. Given bioAffinity Technologies' stronger consensus rating and higher probable upside, equities analysts plainly believe bioAffinity Technologies is more favorable than Mobiquity Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Mobiquity Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor BIAF or MOBQ? In the previous week, bioAffinity Technologies had 1 more articles in the media than Mobiquity Technologies. MarketBeat recorded 1 mentions for bioAffinity Technologies and 0 mentions for Mobiquity Technologies. bioAffinity Technologies' average media sentiment score of 1.43 beat Mobiquity Technologies' score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the media. Company Overall Sentiment bioAffinity Technologies Positive Mobiquity Technologies Neutral Is BIAF or MOBQ more profitable? bioAffinity Technologies has a net margin of -91.22% compared to Mobiquity Technologies' net margin of -279.27%. bioAffinity Technologies' return on equity of -205.09% beat Mobiquity Technologies' return on equity.Company Net Margins Return on Equity Return on Assets bioAffinity Technologies-91.22% -205.09% -115.95% Mobiquity Technologies -279.27%-212.32%-90.57% Which has more risk and volatility, BIAF or MOBQ? bioAffinity Technologies has a beta of 3.45, suggesting that its share price is 245% more volatile than the S&P 500. Comparatively, Mobiquity Technologies has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Does the MarketBeat Community prefer BIAF or MOBQ? bioAffinity Technologies received 1 more outperform votes than Mobiquity Technologies when rated by MarketBeat users. CompanyUnderperformOutperformbioAffinity TechnologiesOutperform Votes150.00% Underperform Votes150.00% Mobiquity TechnologiesN/AN/A SummarybioAffinity Technologies beats Mobiquity Technologies on 12 of the 16 factors compared between the two stocks. Remove Ads Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIAF vs. The Competition Export to ExcelMetricbioAffinity TechnologiesCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.11M$3.11B$5.33B$7.57BDividend YieldN/A2.61%5.11%4.33%P/E Ratio-0.6182.7521.7317.81Price / Sales0.97120.94379.1494.58Price / CashN/A34.5738.1534.64Price / Book0.982.326.464.00Net Income-$7.94M$118.81M$3.20B$247.23M7 Day Performance-14.37%3.09%6.54%7.26%1 Month Performance35.91%-17.37%-8.55%-6.26%1 Year Performance-81.93%-12.48%10.33%-0.18% bioAffinity Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIAFbioAffinity Technologies2.505 of 5 stars$0.50-0.2%$6.00+1,102.9%-78.8%$9.11M$9.36M-0.6110Positive NewsMOBQMobiquity TechnologiesN/A$1.79-5.8%N/A+155.9%$35.75M$1.24M-1.6010KPLTKatapult1.8477 of 5 stars$7.99+7.5%$12.00+50.2%-13.2%$35.64M$247.19M-0.97130Gap UpISDRIssuer DirectN/AN/AN/AN/A$35.35M$33.38M20.49140Analyst ForecastGap UpHigh Trading VolumeVIVKVivakor1.1364 of 5 stars$0.85+6.0%N/A-5.8%$34.78M$61.99M-1.9720Earnings ReportPositive NewsGap DownWKEYWISeKey International1.4866 of 5 stars$4.00-5.4%$4.00+77.8%$34.52M$20.99M0.00140BGSFBGSF3.5864 of 5 stars$3.00+1.4%$9.00+200.0%-67.6%$33.23M$272.50M-30.00400Short Interest ↑GLEGlobal Engine GroupN/A$1.79-2.7%N/AN/A$32.22M$49.45M0.003XBPXBP EuropeN/A$1.04+0.1%N/A-35.4%$31.58M$142.77M0.003Gap DownPMECPrimech1.1148 of 5 stars$0.82-5.2%N/A+19.4%$31.08M$74.31M0.002,744Short Interest ↓News CoverageSJScienjoy1.1312 of 5 stars$0.80+14.5%N/A-23.7%$30.84M$1.44B5.01280Short Interest ↑ Remove Ads Related Companies and Tools Related Companies Mobiquity Technologies Competitors Katapult Competitors Issuer Direct Competitors Vivakor Competitors WISeKey International Competitors BGSF Competitors Global Engine Group Competitors XBP Europe Competitors Primech Competitors Scienjoy Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIAF) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.